Life sciences spotlight — September 2013
DLA Piper has published the second issue of its Life Sciences Spotlight publication for 2013. Contents A new wave of regulatory enforcement actions in China Australia’s innovation patent Best practice disclosure for life sciences companies The new workplace bullying laws and performance management Can reverse payments in patent settlements constitute criminal cartel conduct? Unravelling the […]